本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Turnstone Biologics Corp.

0.3550
0.0000
成交量:- -
成交額:10.17萬
市值:821.49萬
市盈率:-0.17
高:0.3550
開:0.3550
低:0.3550
收:0.3550
52周最高:2.40
52周最低:0.2900
股本:2,314.07萬
流通股本:1,993.03萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.0463
每股收益(LYR):-3.0749
淨資產收益率:-126.71%
總資產收益率:-57.78%
市淨率:0.56
市盈率(LYR):-0.12

資料載入中...

2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/31

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/05

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/24

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/18

SEC問詢函

Form CORRESP - Correspondence
2023/07/18

SEC問詢函

Form CORRESP - Correspondence
2023/07/17

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]